Literature DB >> 8616829

Reduced levels of cathepsin D associated with tamoxifen resistance and estrogen independence in the ZR-75-1 human breast cancer cell line.

B J Long1, H W van den Berg.   

Abstract

The expression and secretion of cathepsin D by ZR-75-1 human breast cancer cells, and tamoxifen-resistant (ZR-75-9a1) and estrogen-independent (ZR-PR-LT) variants was examined by electrophoresis of labeled proteins and Western blotting. Secreted proteins of 160 kDa, 52 kDa and 34 kDa were identified, and in ZR-75-1 cells, they were shown to be estrogen-inducible. Treatment of ZR-75-9a1 cells with 17 beta-estradiol (E2) and the progestin ORG 2058 increased secretion of the 52 kDa protein; ZR-PR-LT cells were unaffected. Western blotting showed that each cell line expressed high levels of the 52 kDa and 34 kDa forms of cathepsin D but that relatively little was being secreted. Each cell line secreted 52 kDa procathepsin D, but 34 kDa mature-cathepsin D was not detected as a secreted protein. ZR-75-1 cells expressed and secreted the highest levels of cathepsin D while ZR-75-9a1 cells expressed and secreted the least.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616829     DOI: 10.1016/0304-3835(95)04098-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae.

Authors:  Martin A Bewley; Trong K Pham; Helen M Marriott; Josselin Noirel; Hseuh-Ping Chu; Saw Y Ow; Alexey G Ryazanov; Robert C Read; Moira K B Whyte; Benny Chain; Phillip C Wright; David H Dockrell
Journal:  Mol Cell Proteomics       Date:  2011-04-07       Impact factor: 5.911

2.  Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis.

Authors:  Junho Kang; Yeuni Yu; Seongdo Jeong; Hansong Lee; Hye Jin Heo; Jeong Jun Park; Hee Sam Na; Dai Sik Ko; Yun Hak Kim
Journal:  Ther Adv Med Oncol       Date:  2020-06-08       Impact factor: 8.168

3.  Association of tamoxifen resistance and lipid reprogramming in breast cancer.

Authors:  Susanne Hultsch; Matti Kankainen; Lassi Paavolainen; Ruusu-Maaria Kovanen; Elina Ikonen; Sara Kangaspeska; Vilja Pietiäinen; Olli Kallioniemi
Journal:  BMC Cancer       Date:  2018-08-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.